definiens: means all of the Patent Rights that are owned solely or jointly by AMRl or any of its Affiliates which ( i ) claim an invention conceived or reduced to practice prior to the Effective Date or during the Combined Period relating to any Amine Neurotransmiuer Reuptake­Inhibitor Compound and/or a composition containing such a compound and/or the research, discovery, identification, Development, manufacture, Commercialization and/or use of such a compound and/or composition, or ( ii ) to the extent not included in ( i ) claim an invention conceived or reduced to practice pursuant to work perfomled under the Research Program relating to a compound, a composition and/or the research, discovery, identification, Development, manufacture, Commercialization and/or use of a compound and/or composition, or ( iii ) to the extent not inel uded in ( i ) and ( ii ), are directed to an [COMPANY] Compound and/or [COMPANY] Compound and/or a composition containing such a compound and/or the research, discovery, identification, Development, manufacture, Commercialization and/or use of such a compound and/or composition . For the avoidance of doubt [COMPANY] Patent Rights include the Attachment A Patent Rights and the Assigned Patent Rights . All of the Assigned Patent Rights as of the Effective Date are listed in Part I of Exhibit 1 . IA, all of the Attachment A Patent Rights as of the Effective Date are listed in Pal1 II of Exhibit ~and all other AMRl Patent Rights as of the Effective Date are listed in Part HI of Exhibit 1.I A